Diabetes & Metabolism Journal

Search

Page Path

HOME
Search

Original Articles

Clinical Care/Education

Is an Oral Glucose Tolerance Test Still Valid for Diagnosing Diabetes Mellitus?: Dong-Lim Kim, Sun-Doo Kim, Suk Kyeong Kim, Sooyoun Park, Kee-Ho Song; Diabetes Metab J. 2016;40(2):118-128. Published online November 20, 2015; DOI: https://doi.org/10.4093/dmj.2016.40.2.118
Cited By 14; Full text PubReader Crossref - TDM PDF

Editorial

Metformin Based Dual-Combination Therapies in Drug Naïve Type 2 Diabetic Patients: Dong-Lim Kim; Diabetes Metab J. 2013;37(6):429-432. Published online December 12, 2013; DOI: https://doi.org/10.4093/dmj.2013.37.6.429
Cited By 3; Full text PubReader Crossref - TDM PDF

Candidate Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes: Yun-Mi Jang, Dong-Lim Kim; Diabetes Metab J. 2011;35(2):117-118. Published online April 30, 2011; DOI: https://doi.org/10.4093/dmj.2011.35.2.117; Full text PubReader Crossref - TDM PDF

Letter

Letter: Risk Factors Associated with Left Ventricular Diastolic Dysfunction in Type 2 Diabetic Patients without Hypertension (Korean Diabetes J 2010;34:40-6): Dong-Lim Kim; Diabetes Metab J. 2010;34(2):135-136. Published online April 30, 2010; DOI: https://doi.org/10.4093/kdj.2010.34.2.135; Full text PubReader Crossref - TDM PDF

Volume 47, No. 2

Diabetes &
Metabolism
Journal

Print ISSN: 2233-6079
Online ISSN: 2233-6087

MOST CITED MOST VIEWED

65,535	Comparison of Insulin-Treated Patients with Ambiguous Diabetes Type with Definite Type 1 and Type 2 Diabetes Mellitus Subjects: A Clinical Perspective
65,535	Sex Differences in the Effects of CDKAL1 Variants on Glycemic Control in Diabetic Patients: Findings from the Korean Genome and Epidemiology Study
65,535	Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study
16,066	2021 Clinical Practice Guidelines for Diabetes Mellitus in Korea
10,090	Insulin Resistance: From Mechanisms to Therapeutic Strategies

Cited By 123	Diabetes Fact Sheets in Korea, 2020: An Appraisal of Current Status
Cited By 84	2021 Clinical Practice Guidelines for Diabetes Mellitus in Korea
Cited By 48	Treatment of Diabetic Kidney Disease: Current and Future
Cited By 42	Insulin Resistance: From Mechanisms to Therapeutic Strategies
Cited By 37	Hyperinsulinemia in Obesity, Inflammation, and Cancer

Editorial Office: 101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-714-9064 Fax: +82-2-714-9084 E-mail: diabetes@kams.or.kr

Copyright © 2023 by Korean Diabetes Association.